Back
Entrada Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
TRDA
Entrada Therapeutics
Last Price:
18.71
Seasonality Move:
-29.61%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight buying pressure.
Entrada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.48 | Sell |
| 20-day SMA: | 18.27 | Sell |
| 50-day SMA: | 16.93 | Buy |
| 200-day SMA: | 15.19 | Buy |
| 8-day EMA: | 18.24 | Sell |
| 20-day EMA: | 18.15 | Sell |
| 50-day EMA: | 17.37 | Buy |
| 200-day EMA: | 15.84 | Buy |
Entrada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 50.91 | Buy |
| Chaikin Money Flow: | 10625 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.04 - 19.04) | Buy |
| Bollinger Bands (100): | (15.03 - 17.89) | Buy |
Entrada Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entrada Therapeutics Stock
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 18.05 while TRDA 8-day simple moving average is 18.48, which is a Sell signal.
- The stock price of TRDA is 18.05 while Entrada Therapeutics 20-day SMA is 18.27, which makes it a Sell.
- Entrada Therapeutics 50-day simple moving average is 16.93 while TRDA share price is 18.05, making it a Buy technically.
- TRDA stock price is 18.05 and Entrada Therapeutics 200-day simple moving average is 15.19, creating a Buy signal.
TRDA Technical Analysis vs Fundamental Analysis
Buy
58
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy or a Sell?
-
Entrada Therapeutics stock is rated a Buy
The current Entrada Therapeutics [TRDA] share price is $18.05. The Score for TRDA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Entrada Therapeutics Stock Info
Market Cap:
675.43M
Price in USD:
18.05
Share Volume:
85K
Entrada Therapeutics 52-Week Range
52-Week High:
20.49
52-Week Low:
10.75
Buy
58
Entrada Therapeutics (TRDA)
is a Buy
Entrada Therapeutics Share Price Forecast
-
What is the Entrada Therapeutics stock price today?
The Entrada Therapeutics stock price is 18.05 USD today. -
Will TRDA stock go up or go down?
Entrada Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Entrada Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics is not overvalued.
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 18.05 while TRDA 8-day exponential moving average is 18.24, which is a Sell signal.
- The stock price of TRDA is 18.05 while Entrada Therapeutics 20-day EMA is 18.15, which makes it a Sell.
- Entrada Therapeutics 50-day exponential moving average is 17.37 while TRDA share price is 18.05, making it a Buy technically.
- TRDA stock price is 18.05 and Entrada Therapeutics 200-day simple moving average is 15.84, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics
Is Entrada Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.
Technical Analysis of Entrada Therapeutics
Should I short Entrada Therapeutics stock?
- TRDA Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Entrada Therapeutics is a Buy
- Entrada Therapeutics Relative Strength Index (RSI) is 50.91, which suggest Entrada Therapeutics is overbought
- The Bollinger Bands (25) for Entrada Therapeutics is (17.04 - 19.04), which suggest Entrada Therapeutics is a Buy
- The Bollinger Bands (100) for Entrada Therapeutics is (15.03 - 17.89), which suggest Entrada Therapeutics is a Buy
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.